Loperamide hydrochloride
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
The active substance of AuroBlock Fast is loperamide hydrochloride. It belongs to a group of medicines called "anti-diarrheal" used to treat diarrhea. AuroBlock Fast is used to treat the symptoms of acute diarrhea in adults and children from 15 years of age. AuroBlock Fast should not be used for more than 2 days without medical consultation. During treatment, it is essential to drink plenty of fluids and follow dietary recommendations (see section 2 "Warnings and precautions").
Before starting to take AuroBlock Fast, the patient should discuss it with a doctor or pharmacist:
During treatment, the following dietary rules should be followed:
AuroBlock Fast only suppresses diarrhea, it does not treat its cause. Whenever the cause can be identified, it should be treated accordingly. Therefore, the patient should talk to a doctor. This medicine should not be taken for purposes other than its intended use (see section 1) and never take more than the recommended amount (see section 3). In patients who have taken too much loperamide, the active substance of AuroBlock Fast, serious heart problems have been reported (symptoms of which are rapid or irregular heartbeat). AuroBlock Fast usually stops diarrhea within 48 hours of the first administration. If diarrhea persists after two days of treatment with AuroBlock Fast, the use of AuroBlock Fast should be discontinued, and a doctor should be consulted.
This medicine should not be used in children under 15 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. In particular, the patient should discuss with their doctor if it is necessary to regularly or occasionally take one or more of the following medicines:
It is expected that medicines with a similar mechanism of action to AuroBlock Fast may enhance its effect, and medicines that accelerate gastrointestinal passage may weaken its effect.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before taking this medicine.
The use of AuroBlock Fast is not recommended during pregnancy.
The use of this medicine is not recommended during breastfeeding, as small amounts of loperamide may pass into breast milk.
During the treatment of acute diarrhea with AuroBlock Fast, dizziness, fatigue, and drowsiness may occur. Therefore, the patient should be cautious when driving or operating machinery.
This medicine contains less than 1 mmol (23 mg) of sodium per orally disintegrating tablet, which means it is considered "sodium-free". This medicine contains 5 mg of aspartame per orally disintegrating tablet. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria, a rare genetic disorder, in which phenylalanine accumulates because the body cannot remove it properly. This medicine contains sucrose (a type of sugar). If the patient has been informed by their doctor that they have an intolerance to some sugars, they should consult their doctor before taking this medicine.
AuroBlock Fast should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult a doctor or pharmacist.
Age | Initial dose | Supplementary dose | Maximum daily dose |
Adolescents from 15 years | 1 tablet | 1 tablet | 4 tablets |
Adults | 2 tablets | 1 tablet | 6 tablets |
AuroBlock Fast should not be used in children under 15 years of age due to the high content of the active substance. Other medicines are available for this population.
The orally disintegrating tablet should be placed on the tongue. The tablet disintegrates immediately on the tongue and can be swallowed. No liquid is needed to swallow.
AuroBlock Fast should not be taken for more than 2 days without medical consultation. If diarrhea persists after two days of treatment with AuroBlock Fast, the use of AuroBlock Fast should be discontinued, and a doctor should be consulted. Treatment with medicines containing loperamide hydrochloride should not last longer than 2 days without medical consultation and monitoring. If the patient feels that the effect of AuroBlock Fast is too strong or too weak, they should consult a doctor or pharmacist.
In case of overdose, the patient should immediately consult a doctor or hospital emergency department for advice. Symptoms may include:
Children react more strongly to large amounts of AuroBlock Fast than adults. If a child has taken too much medicine or shows any of the above symptoms, they should immediately consult a doctor. Information for the doctor in case of overdose: Symptoms of loperamide hydrochloride overdose may also occur after relative overdose due to liver function disorders. Treatment depends on the symptoms of overdose and clinical diagnosis. During medical observation, EKG monitoring should be started to check for QT interval prolongation. If symptoms from the central nervous system occur after overdose, the opioid antagonist naloxone can be administered as an antidote. Since loperamide has a longer duration of action than naloxone, it may be necessary to repeat the administration of naloxone. Therefore, the patient should be closely monitored for at least 48 hours to diagnose possible occurrence/recurrence of overdose symptoms.
A double dose should not be taken to make up for a missed dose. In case of any further doubts about the use of this medicine, the patient should consult a doctor or pharmacist.
Like all medicines, AuroBlock Fast can cause side effects, although not everybody gets them. The most commonly reported side effects in clinical trials were constipation, bloating, headache, nausea, and dizziness. If any of the following symptoms occur, the patient should stop taking AuroBlock Fast and seek medical help immediately:
Frequent (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known (frequency cannot be estimated from the available data)
Frequent (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Certain difficulties may be caused by diarrhea itself: abdominal pain, nausea, vomiting, dry mouth, fatigue, drowsiness, dizziness, constipation, and bloating. After taking AuroBlock Fast tablets, a transient burning or stinging sensation in the tongue may occur.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be gathered on the safety of the medicine. Side effects can also be reported to the marketing authorization holder.
The medicine should be stored out of sight and reach of children. This medicine should not be used after the expiry date stated on the carton and blister after EXP. The expiry date refers to the last day of the month. The medicine should not be stored above 25°C. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance is loperamide hydrochloride. Each orally disintegrating tablet contains 2 mg of loperamide hydrochloride. The other ingredients are: sodium croscarmellose, aspartame E 951, fruit flavor (containing: arabic gum E 414, sugar (sucrose), maltodextrin (potato), triacetin, propylene glycol), banana flavor (containing corn maltodextrin), magnesium stearate, mannitol.
Round, white or almost white tablets with a diameter of about 7 mm. AuroBlock Fast, 2 mg, orally disintegrating tablets are available in packs of 6, 10, 12, 20, and 30 orally disintegrating tablets, in a cardboard box. Not all pack sizes may be marketed.
Aurovitas Pharma Polska Sp. z o.o. ul. Sokratesa 13D lokal 27 01-909 Warsaw e-mail: medicalinformation@aurovitas.pl
Tiofarma B.V. Hermanus Boerhaavestraat 1 3261 ME, Oud-Beijerland Netherlands
Loperamide AB 2 mg Orodispergeerbare tabletten/comprimés orodispersibles/Schmelztabletten
LOPERAMIDE ARROW CONSEIL 2 mg, comprimé Orodispersible
Loperamide PUREN akut 2mg schmelztabletten
AuroBlock Fast
Loperamida Ritisca
Diarrhea causes loss of fluids and salts. This medicine treats the symptoms of acute diarrhea in adults and children from 15 years of age, but hydration should not be abandoned in combination with a healthy diet. Therefore, it is necessary to drink plenty of sugary drinks (fruit juices) and salty broths to compensate for these losses. The patient should avoid consuming milk, green vegetables, raw vegetables, fruits, and spices until the diarrhea subsides.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.